1 + 1 > 2, Bioer signed a strategic cooperation agreement with Sinopharm foreign trade
On April 13, Bioer and China Pharmaceutical Foreign Trade Co., Ltd. (hereinafter referred to as "Sinopharm foreign trade") held a strategic cooperation agreement signing ceremony in Beijing. Yu Hai, general manager of Bioer, and Ding Weizuo, general manager of Sinopharm foreign trade signed the contract on behalf of both parties. Chen Zhijuan, deputy general manager of Bioer, Li Dong, technical director, sun Tai, deputy general manager of Sinopharm foreign trade, Chen Xiangjun, chief financial officer, etc. attended the ceremony.
Signing site
General manager Yu Hai introduced the expansion plan of Bioer's overseas business, and pointed out the importance and strategic position of the overseas market to the company's overall development, especially the company's molecular diagnostic products enjoy a high reputation in domestic and foreign markets. He also expressed the hope that the two sides would work together to further develop the international market on the basis of the current friendly cooperation of optical digital imaging products.
Speech by Ding Weizuo, general manager of Sinopharm foreign trade
General manager Ding Weizuo briefly introduced the development orientation of Sinopharm foreign trade in international business, overseas network layout, international business development experience and international strategy implementation measures.
Responding to "one belt, one road", we will start playing well the brand of "China Intelligent Manufacturing".
China's pharmaceutical China China Foreign Trade China one belt, one road, is a member of China International Medical and Health Limited company. It is a comprehensive life and health industry cluster in China and Asia, and is a member of China Pharmaceutical Group Co., Ltd., which was founded in 1981.
Sinopharm foreign trade is mainly engaged in international trade and industrial investment of medicine and related products, integrates a variety of business models, forms diversified business segments such as authorized distribution of medical devices, marketing of Medicine / health products, overseas business, medical project coordination and bonded logistics, and provides a number of value-added services such as after-sales maintenance, overseas registration and information consultation. brand
Group photo
The signing of this strategic cooperation agreement is an important measure for both sides to comprehensively deepen strategic cooperation around jointly building the brand value of "Bioer" in the international market. The two sides will give full play to their respective resource advantages, conduct all-round business cooperation at international business, capital operation and other levels, and provide better products and services for global customers.
China and China will one belt, one road, one more and better "China's smart" products, and the other is to go global to "go global" and jointly create the brand value of "China's wisdom" in the international market.
--> Return to list